Sunday, December 21, 2014   

Two men die after taking new drug
(02-04 16:46)

Two men have died after taking a new type of drug known as PMMA -- the first such cases reported in Hong Kong.
The Poison Information Center says the drug -- which stimulates the brain and heart -- can quickly prove fatal.
The men both died a day or two after being admitted to hospital. Other drugs were also found in their bodies.
The centre says PMMA can cause high blood pressure, rapid heart beat, fever, dilated pupils and seizures.
It says PMMA is dangerous because it's often mixed with other drugs before being repackaged like sweets in bright colors that are attractive to young people. --RTHK   
Other Hong Kong breaking news:
(SHKP trial) Thomas Kwok steps down as chairman (12-19 19:24)
(SHKP trial) Two middlemen detained after convicted (12-19 18:50)
(SHKP trial) Verdicts for high profile bribery case of Rafael Hui, Kwok borthers (12-19 18:35)
(SHKP trial) Rafael Hui: from top official to convicted (12-19 18:16)
(SHKP trial) Billionaire brothers at heart of trial (12-19 18:11)
(SHKP trial) ICAC remains unbiased in investigations (12-19 17:13)
(SHKP trial) Jurors exempted from jury duty in five years (12-19 17:00)
(SHKP trial) Raymond Kwok thankful his name cleared (12-19 16:42)
(SHKP trial) Alan Leong calls for improvement in vetting and disclaration system (12-19 16:35)
(SHKP trial) 'Black eye' for Hong Kong: analyst (12-19 16:32)

More breaking news >>

© 2014 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2014, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.